Skip to main content
Publications
Halsby K, Dobler G, Easton A, Karelis G, Krbkova L, Kyncl J, Sellner J, Strle F, Veje M, Zajkowska J, Zavadska D, Angulo FJ, Pilz A, Erber W, Gabriel M, Russo J, Price M , Madhava H, Meyding-Lamade UK. Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: a Delphi panel . Ticks Tick Borne Dis. 2025 Jan;16(1):102431. doi: 10.1016/j.ttbdis.2024.102431
Samuelsson K, Rivas I, Raimbault B, Dominguez A, Galmes T, Valentin A, Foraster M , Gascon M, Persavento C, Psyllidis A, Gomez Roig MD, Olive EL, Nieuwenhuijsen MJ, Helbich M, Sunyer J, Dadvand P. A comprehensive GPS-based analysis of activity spaces in early and late pregnancy using the ActMAP framework . Health Place. 2025 Jan;91:103413. doi: 10.1016/j.healthplace.2025.103413
Cappellini MD, Glassberg MB, Meyers J , Jimenez M , Nham T , Bueno L, Sieluk J, Yucel A, Alashkar F. Demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia: a retrospective medical record abstraction study . Ther Adv Hematol. 2024 Dec 15;15. doi: 0.1177/20406207241298088
Pistillo A, Warkentin S, Abellan A , de Bont J, Ranger T, Perez-Crespo L, Cirach M, Perramon-Malavez A, Khalid S, Nieuwenhuijsen M, Vrijheid M, Duarte-Salles T. Residential relocation and changes in patterns of environmental exposures by health determinants among children and adolescents in Catalonia, Spain . Environ Res. 2024 Dec 15;263(Pt 2):120152. doi: 10.1016/j.envres.2024.120152
Sutton Norman K , Zigler C, Brown M, Miller J, Bosworth H, Collyar D, Oakes M, Fowler V, Howard-Anderson J, Korn R, Ruffin F, Boucher H, Doemberg S, Reeve B, King H. Patient and clinician perspectives of care interactions for complicated urinary tract infections to inform implementation of patient-reported outcome measures: a qualitative descriptive study . Poster presented at the 17th Annual Conference on the Science of Dissemination and Implementation in Health; December 9, 2024. Arlington, VA.
Shadman M, Roeker L, Pinilla-Ibarz J, Srivastava B, Karve S, Krigsfeld GS, Franceschini E, Saifan C, Karanth S , Goyal RK , Rombi J , Stephens DM. Association between dose reduction and duration of therapy in patients receiving ibrutinib or acalabrutinib for chronic lymphocytic leukemia: a medical chart review study . Poster presented at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition; December 8, 2024. San Diego, California.
Kosa K , Vanegas A, Colavecchia C, Coulter J, Christopher SA, Fasano RM, Chou ST, Drachtman RA, Purdie DM, Baker CL, Meier ER. Qualitative interview study to characterize the treatment experiences of participants with sickle cell disease and assess perceptions of red blood cell transfusions . Poster presented at the American Society of Hematology (ASH) Annual Meeting & Exposition; December 8, 2024. San Diego, CA.
Benitez A, Andrews JS, Shah D, Mansfield C, Ross E, Rao S, Bussberg C , Galinksy J , Konermann-Bernhardt C, Lu M, Vass C . Caregiver preferences for dravet syndrome and lennox-gastaut syndrome treatments across the USA, UK, and Germany . Poster presented at the 2024 American Epilepsy Society (AES) Annual Meeting; December 7, 2024. Los Angeles, CA.
Krishnamurthy P, Houghton K , Lorenz N, Williams P, Currie L, Vigil CE, Ziba N , Bello F , Sieluk J, Strocchia M, Li Y, Kapp-Schwoerer S. Real-world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemia . Poster presented at the American Society of Hematology (ASH) Annual Meeting & Exposition; December 7, 2024. San Diego, CA.
Ahn MJ, Lin SH, Yang CT, Lee JB, Neal J, Okishio K, Nishino K, Smith D, Rauter M, Jimenez M , Nagar SP, Nasirova F, Kim YJ. Treatment (Tx) patterns and clinical outcomes in unresectable (UR) stg III EGFR-mutation positive (EGFRm) NSCLC treated with chemoradiotherapy (CRT): final analysis of a global real-world (rw) study . Poster presented at the European Society for Medical Oncology (ESMO) Asia Congress 2024; December 7, 2024. Singapore, China.
Rao S , McQuay L, Forns J , MacKay R , Aquilina T, Doshi D, Abler V, Anthony MS , Layton B . Mortality in patients with Parkinson's disease psychosis using pimavanserin versus other antipsychotics . Poster presented at the 2024 Parkinson Study Group (PSG) 33rd Annual Meeting; December 5, 2024. Nashville, TN. Previously presented at the Neuroscience Education Institute (NEI) Congress 2024.
Grivas P, Barata P, Moon H, Gupta S, Hutson T, Sternberg CN, Brown JR, Dave V, Downey C , Shillington AC, Katzenstein HM, Kirker M, Hanson S, Liu FX, Morris V, Bhanegaonkar A, Sonpavde GP. Avelumab first-line maintenance for locally advanced or metastatic urothelial carcinoma: results from the Real-world US PATRIOT-II Study . Clin Genitourin Cancer. 2024 Dec;22(6):102238. doi: 10.1016/j.clgc.2024.102238
Wainberg ZA, Enzinger PC, Qin S, Yamaguchi K, Wang J , Zhou X , Gnanasakthy A , Taylor K, Yusuf A, Maher I, Jamotte A, Kang YK. Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer . ESMO gastrointestinal oncology. 2024 Dec;6. doi: 10.1016/j.esmogo.2024.100095
Neofytos D, Pagliuca A, Houghton K , Broughton E, de Figueiredo Valente MLN, Jiang L, Enoch DA, Gruener B, Herbrecht R, Lahmer T, Lortholary O, Melenotte C, De Rosa FG, Garcia-Vidal C, Jimenez M , Fernandez M, Cornely O. Effectiveness, safety, and patterns of real-world isavuconazole use in Europe (2015-2019) . Infect Dis Ther. 2024 Dec;13(12):2527-43. doi: 10.1007/s40121-024-01064-4
Druce KL , Yimer BB, Humphreys J, Njuki LN, Bourke D, Li M, Ellis B, Zhang Y, Bravo R, Hyrich KL, Verstappen SMM, Dixon WG, McBeth J. The epidemiology of psoriatic arthritis in the UK: a health intelligence analysis of UK primary care electronic health records 1991-2020 . Rheumatology. 2024 Dec 1;63(12):3346-52. doi: 10.1093/rheumatology/kead586
Neches V, Campbell K , Coll P, Moreno Guillen S, Martinez-Sesmero JM, Lopez Segui F, O'Brien P, Davis A , Anderson SJ, Schroeder M, Vallejo-Aparicio LA. Cost-effectiveness of cabotegravir long-acting for pre-exposure prophylaxis versus current use of daily oral tenofovir disoproxil fumarate/emtricitabine or no prep to prevent HIV-1 in individuals at high risk in Spain . Poster presented at the ISPOR Europe 2024; November 17, 2024. Barcelona, Spain. [abstract] Value Health. 2024 Dec; 27(12 Supplement):S121. doi: 10.1016/j.jval.2024.10.620
Desai A, Dong OM , Gautier S, Johnson T, Wong A, Osman AMY, Harvey J, Tran TH, Holladay Ford DM, Kerr KW, Aggarwal A, Mauskopf J. A systematic review of health economic evaluations of oral nutritional supplements as a single-component or multi-component intervention in older adults with or at risk of malnutrition . Poster presented at the ISPOR Europe 2024; November 18, 2024. Barcelona, Spain. [abstract] Value Health. 2024 Dec; 27(12):S120.
Dominguez A, Dadvand P, Cirach M, Arevalo G, Barril L, Foraster M , Gascon M, Raimbault B, Galmes T, Gomez-Herrera L, Persavento C, Samuelsson K, Lao J, Moreno T, Querol X, Jerrett M, Schwartz J, Tonne C, Nieuwenhuijsen MJ, Sunyer J, Basagana X, Rivas I. Development of land use regression, dispersion, and hybrid models for prediction of outdoor air pollution exposure in Barcelona . Sci Total Environ. 2024 Dec 1;954:176632. doi: 10.1016/j.scitotenv.2024.176632